United-Guardian Profit Margin 2006-2019 | UG

Current and historical gross margin, operating margin and net profit margin for United-Guardian (UG) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. United-Guardian net profit margin as of September 30, 2019 is 31.01%.
United-Guardian Annual Profit Margins
United-Guardian Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.092B $0.014B
UNITED GUARDIAN conducts research, product development, manufacturing and marketing of pharmaceuticals, cosmetics, health care products, medical devices, and proprietary industrial products. They also distributes a line of over 3,000 fine organic chemicals, research chemicals, test solutions, indicators, dyes and reagents.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $150.637B 27.48
Medtronic (MDT) Ireland $150.042B 20.73
Stryker (SYK) United States $76.456B 25.71
Boston Scientific (BSX) United States $59.948B 28.30
Baxter (BAX) United States $42.085B 25.52
Essilor Luxottica (ESLOY) France $33.039B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.517B 19.15
Terumo (TRUMY) Japan $27.707B 34.58
Coloplast (CLPBY) Denmark $25.466B 39.30
Lonza Group Ag (LZAGY) Switzerland $25.140B 0.00
ResMed (RMD) United States $21.589B 39.83
Smith & Nephew SNATS (SNN) United Kingdom $19.156B 0.00
Sunny Optical Technology (SNPTF) China $17.572B 0.00
Insulet (PODD) United States $11.307B 537.91
Bio-Rad Laboratories (BIO) United States $11.116B 53.36
DiaSorin S.p.A (DSRLF) Italy $7.580B 0.00
William Demant Holdings (WILYY) Denmark $7.531B 0.00
Hill-Rom Holdings (HRC) United States $7.111B 20.97
Perrigo (PRGO) Ireland $6.899B 12.86
Canopy Growth (CGC) Canada $6.407B 0.00
Haemonetics (HAE) United States $6.041B 40.82
Shandong Weigao Medical Polymer (SHWGF) China $5.743B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 27.26
NuVasive (NUVA) United States $3.822B 30.09
ICU Medical (ICUI) United States $3.799B 24.77
Neogen (NEOG) United States $3.543B 59.28
GW Pharmaceuticals (GWPH) United Kingdom $3.272B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.243B 0.00
Quidel (QDEL) United States $2.849B 27.04
Aurora Cannabis (ACB) Canada $2.702B 0.00
Agios Pharmaceuticals (AGIO) United States $2.371B 0.00
National Vision Holdings (EYE) United States $2.367B 53.43
Cardiovascular Systems (CSII) United States $1.555B 0.00
InMode (INMD) Israel $1.371B 0.00
Aphria (APHA) $1.175B 0.00
AtriCure (ATRC) United States $1.173B 0.00
VAREX IMAGING (VREX) United States $1.161B 23.26
Phibro Animal Health (PAHC) United States $0.983B 18.41
NanoString Technologies (NSTG) United States $0.953B 0.00
TG Therapeutics (TGTX) United States $0.816B 0.00
Lantheus Holdings (LNTH) United States $0.793B 19.80
Eagle Pharmaceuticals (EGRX) United States $0.762B 29.17
Omeros (OMER) United States $0.758B 0.00
LeMaitre Vascular (LMAT) United States $0.719B 40.44
Quanterix (QTRX) United States $0.689B 0.00
PetIQ (PETQ) United States $0.644B 15.72
Cerus (CERS) United States $0.587B 0.00
Surmodics (SRDX) United States $0.553B 57.44
HEXO (HEXO) $0.548B 0.00
OraSure Technologies (OSUR) United States $0.476B 28.56
MacroGenics (MGNX) United States $0.473B 0.00
Owens & Minor (OMI) United States $0.439B 16.23
Organigram Holdings (OGI) Canada $0.401B 0.00
Utah Medical Products (UTMD) United States $0.395B 28.61
Meridian Bioscience (VIVO) United States $0.389B 13.37
Zynex (ZYXI) United States $0.341B 38.52
BioLife Solutions (BLFS) United States $0.332B 135.17
Bovie Medical (APYX) United States $0.271B 0.00
United Health Products (UEEC) United States $0.263B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.256B 0.00
Viemed Healthcare (VMD) United States $0.230B 24.28
Vapotherm (VAPO) United States $0.223B 0.00
Liberty Health Sciences (LHSIF) Canada $0.187B 0.00
Repro-Med Systems (KRMD) United States $0.187B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.178B 0.00
InfuSystems Holdings (INFU) United States $0.158B 796.00
Chimerix (CMRX) United States $0.155B 0.00
Female Health (VERU) United States $0.142B 0.00
Rockwell Medical (RMTI) United States $0.134B 0.00
MTech Acquisition (KERN) United States $0.128B 0.00
Fonar (FONR) United States $0.127B 8.92
Cytosorbents (CTSO) United States $0.122B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.081B 0.00
Chembio Diagnostics (CEMI) United States $0.071B 0.00
Nephros (NEPH) United States $0.063B 0.00
MRI Interventions (MRIC) United States $0.058B 0.00
Surface Oncology (SURF) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Trinity Biotech (TRIB) Ireland $0.025B 0.00
Senestech (SNES) United States $0.016B 0.00
GUARDION HEALTH (GHSI) United States $0.016B 0.00
Valeritas Holdings (VLRX) United States $0.013B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Myomo (MYO) United States $0.008B 0.00
Capricor Therapeutics (CAPR) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00
Akers Biosciences Inc (AKER) United States $0.003B 0.00